Skip to main content
Article
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
European Urology (2021)
  • Andres F. Correa, Fox Chase Cancer Center
  • Opeyemi A. Jegede, Harvard University
  • Naomi B. Haas, University of Pennsylvania
  • Keith T. Flaherty, Harvard University
  • Michael R. Pins, Advocate Lutheran General Hospital
  • Adebowale Adeniran, Yale University
  • Edward M. Messing, University of Rochester
  • Judith Manola, Harvard University
  • Christopher G. Wood, University of Texas MD Anderson Cancer Center
  • Christopher J. Kane, University of California, San Diego
  • Michael A.S. Jewett, Princess Margaret Cancer Centre
  • Janice P. Dutcher, National Foundation for Cancer Research
  • Robert S. DiPaola, University of Kentucky
  • Michael A. Carducci, Johns Hopkins University
  • Robert G. Uzzo, Fox Chase Cancer Center
Publication Date
July 1, 2021
DOI
10.1016/J.EURURO.2021.02.025
Citation Information
Andres F. Correa, Opeyemi A. Jegede, Naomi B. Haas, Keith T. Flaherty, et al.. "Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma." European Urology Vol. 80 Iss. 1 (2021) p. 20 - 31
Available at: http://works.bepress.com/andres-correa/44/